Viemed Healthcare (VMD) Gains from Investment Securities (2018 - 2024)
Viemed Healthcare (VMD) posted Gains from Investment Securities of $98000.0 for Q2 2024, up 100.0% on a QoQ basis from $49000.0 in Q1 2024, and down 50.0% year-over-year from $196000.0 in Q3 2023.
Viemed Healthcare (VMD) Gains from Investment Securities (2018 - 2024) Analysis & Trends
Viemed Healthcare's Gains from Investment Securities history runs 5 years deep, the most recent figure standing at $98000.0 for Q2 2024.
- Quarterly Gains from Investment Securities fell 50.0% year-over-year to $98000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $98000.0 (down 88.24% YoY) and the FY2024 annual result came in at $147000.0, down 85.0% from the prior year.
- Gains from Investment Securities was $98000.0 for Q2 2024 at Viemed Healthcare, up from $49000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $441000.0 in Q3 2023 and bottomed at $49000.0 in Q1 2024.
- A 3-year average of $220600.0 and a median of $196000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities soared 38.24% — and 2024, when it plunged 75.0%.
- Viemed Healthcare's Gains from Investment Securities stood at $148000.0 in 2022, then slipped by 0.68% to $147000.0 in 2023, then slumped by 33.33% to $98000.0 in 2024.
- Business Quant data shows VMD's Gains from Investment Securities at $98000.0 in Q2 2024, $49000.0 in Q1 2024, and $147000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Viemed Healthcare | 465.75 Mn | 455.99 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 98,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 147,000.00 |
| Dec 31, 2023 | 147,000.00 |
| Sep 30, 2023 | 441,000.00 |
| Sep 30, 2023 | 441,000.00 |
| Jun 30, 2023 | 196,000.00 |
| Jun 30, 2023 | 196,000.00 |
| Mar 31, 2023 | 196,000.00 |
| Mar 31, 2023 | 196,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Sep 30, 2022 | 319,000.00 |
| Sep 30, 2022 | 319,000.00 |
| Jun 30, 2022 | 391,000.00 |
| Jun 30, 2022 | 391,000.00 |
| Mar 31, 2022 | 221,000.00 |
| Mar 31, 2022 | 221,000.00 |